News
Fe3 Medical Announces Results Of First Human Study Of Transdermal Patch That Uses Electricity To Deliver Iron
Fe3 Medical, the creators of a transdermal patch for the treatment of iron deficiency anemia, today announced the results from its first human study of the Fe3 proprietary biphasic iontophoretic transdermal technology.
Read More
April 11, 2019
Fe3 Medical Completes First Human Study of Electric Transdermal Iron Patch
For many people with Crohn’s disease, inflammatory bowel disease or gastric bypass operations, it can be hard to maintain sufficient levels of iron in the bloodstream. That can be harder still when oral iron pills can cause intolerable nausea, constipation, and diarrhea. But now, Fe3 Medical is moving forward with its wearable patch that uses electrical current to deliver iron directly through the skin to treat one of the world’s most common deficiencies.
Read More
April 11, 2019
Patch Offers a New Approach for Treating Iron Deficiency
Fe3 Medical completed the first human study of its iontophoretic transdermal technology designed to bypass ionic resistance build up in the skin.
Read More
April 15, 2019
Fe3 Medical concludes the first human study of iontophoretic transdermal technology
Fe3 Medical concludes the first human study of iontophoretic transdermal technology
Read More
April 12, 2019
Transdermal Patch Uses Electricity to Deliver Iron to Patients with Iron Deficiency
The human study was conducted at a Clinical Research Organization (CRO) in Texas, under the Investigational Review Board (IRB) approval. The company conducted safety and tolerability studies, evaluating iron transport with Fe3's proprietary transdermal platform in forty healthy volunteers.
Read More
April 12, 2019